USERRA Judgment

SLG recently prevailed in an arbitration in Tampa, Florida, against Northrop Grumman Corporation.  Northrop Grumman fired SLG’s client, a Major in the Air Force Reserve, while he was on active duty.  The Arbitrator found that this termination was the result of a “witch hunt” and careless “investigation” in violation of the Uniformed Services Employment and Reemployment Rights Act (“USERRA”).  The […]

November 28, 2018

Judge Frank P. Geraci, Jr.’s Judgment

Judgment entered in favor of SLG’s client Mimetogen Pharmaceuticals Inc.’s counterclaim against Bausch & Lomb Incorporated in the United States District Court for the Western District of New York Bausch & Lomb Incorporated v. Mimetogen Pharmaceuticals Inc. See Judge Frank P. Geraci, Jr.’s Judgment here.

March 1, 2018

Judge Frank P. Geraci, Jr.’s Opinion

Decision and Order denying Valeant Pharmaceuticals International, Inc.’s, Motion for Summary Judgment and granting Mimetogen Pharmaceutical Inc.’s Motion for Partial Summary Judgment issued on behalf of SLG’s client, Mimetogen Pharmaceuticals Inc., in the United States District Court for the Western District of New York in Bausch & Lomb Incorporated v. Mimetogen Pharmaceuticals Inc. Read Judge Frank P. Geraci, Jr.’s Opinion […]

July 25, 2017

Judge Frank Geraci, Jr.’s Decision

New York federal court denies motion to dismiss (in part) and permits SLG’s client, Mimetogen Pharmaceuticals, Inc., to pursue extra-contractual damages outside of contractual limitation on liability in breach of contract claim against Bausch & Lomb Incorporated, and permits claim for tortious interference with contract against Valeant Pharmaceuticals International, Inc. Read Judge Frank Geraci, Jr.’s Decision here.

May 5, 2016

Former Harmonix Stockholders Defeat Viacom International’s Motion to Dismiss

Former Harmonix Stockholders Defeat Viacom International’s Motion to Dismiss; Judge Rules that Case May Proceed. Read Judge Eric M. Davis’s Opinion regarding SLG client, Walter Winshall, representing former Harmonix Stockholders, here.

February 29, 2016

David Shlansky, Esq., quoted in Financial Post Article

Bausch & Lomb Incorporated v. Mimetogen Pharmaceuticals Inc.: David Shlansky, Esq., quoted in Financial Post article regarding SLG’s client, Mimetogen Pharmaceuticals Inc., and its dispute with Bausch & Lomb Incorporated. Read “The behemoth, the biotech and the break fee: How a small Canadian firm ended up in a legal battle with Valeant Pharmaceuticals International Inc.” here.

February 8, 2016

Manager Rule

Client Update: SLG’s Colin Hagan recently completed an extensive examination of the “Manager Rule” and has compiled his findings in the article titled ‘”Manager Rule” Not the Rule in Fourth Circuit.’ Read the full article here.

July 7, 2014

Massachusetts Office Has Moved

SLG is pleased to announce that our Massachusetts office has moved! Located at 1 Winnisimmet Street, in Chelsea, our new office offers more space and improved accessibility to better serve our growing client base.

June 25, 2014

David Shlansky, quoted on Bloomberg.com’s Apple-Samsung article.

SLG Managing Partner, David Shlansky, was quoted on Bloomberg.com’s Apple-Samsung article. Read the article, including David’s commentary, here.

April 29, 2014